Impact of CYP2D6 Genetic Polymorphism on Tramadol Pharmacokinetics and Pharmacodynamics

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.11, Iss.3, 2007-01, pp. : 171-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP2D6*4 polymorphism, tramadol treatment and its clinical impact in patients with postherpetic neuralgia

By Nasare Namita Vilas Deshmukh Pravin Suryakantrao Banerjee Basu Dev Mediratta Pramod Kumari Ahmed Rafat S Saxena Ashok Kumar Bhattacharya Sambit Nath

Personalized Medicine, Vol. 9, Iss. 4, 2012-06 ,pp. : 371-385

Future Medicine

Access to resources Recommend Favorite

CYP2D6 genetic polymorphism and psychiatry patients’ hospitalization period

By Peñas-LLedó Eva M LLerena Adrián

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 915-916

Future Medicine

Access to resources Recommend Favorite

Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 6, 2015-06 ,pp. : 680-687

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of the CYP2D6 gene polymorphism on the risk of pemphigoid

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 12, 2015-12 ,pp. : 1396-1401

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 2, 2015-04 ,pp. : 226-231

John Wiley & Sons Inc

Access to resources Recommend Favorite